BioHarvest Announces Appointment of Sharon Malka to Board of Directors
Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the BoardVancouver, British Columbia and Rehovot, Israel--(Newsfile...
Month: January 2025
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - January 22, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - January 22, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Live webcast on Wednesday, January 29th at 2:00 PM ETISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc....
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment...
Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
- Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll...
NeuroSigma Announces Patent Application Protecting Use of Trigeminal Nerve Stimulation to Include Treatment of Dyslexia and Other Neurodevelopmental Disorders
LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve...
NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth...
HTM College Education: AAMI Sets New Standard
First-ever standard for training biomedical, clinical engineersArlington, Virginia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- There are relatively few healthcare technology...
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Live webcast on Wednesday, January 29th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics...
New Natural Sleep Aid Innovation Combines Traditional Ingredients With Modern Science
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 22, 2025 / Perfiby, a California-based wellness company, today announced the launch...
Biodexa Strengthens Management Team – Appointment of Dr Gary A. Shangold as Chief Medical Officer
January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC...
Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease (MVID), with Proof-of-Concept (POC) Data Potentially Available H1 2025
Trial taking place at Sheikh Khalifa Medical City, a flagship tertiary hospital in the United Arab EmiratesPOC data generated from...
AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS The...
KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus
The hospital location positions KindlyMD to expand its core service offerings into Weber County SALT LAKE CITY, UT / ACCESS...
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE...
Ursamin Pilots Achieve Measurable Results in Streamlining Care Coordination Workflows
Pilot studies deliver significant time savings and streamline workflows for primary care teams. FAYETTEVILLE, NY / ACCESS Newswire / January...
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage...
Tiny Health Launches Index Predicting Child’s Gut Microbiome Age
AUSTIN, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiny Health, a leader in at-home gut microbiome testing, today announced the...
Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
~ Positive Phase 1b Data Confirms Overdose Protection for Highest Dosage Form of PF614-MPAR ~ SAN DIEGO, CA / ACCESS...